Relative potency of nitrovasodilators on human placental vessels from normal and preeclamptic pregnancies

Gynecologic and Obstetric Investigation

Volumn 43, Issue 4, 1997, Pages 219-224

  Gonzalez C ^a   Cruz, M A ^a   Gallardo, V ^a   Miguel, P ^a   Carrasco, G ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Chorionic arteries and veins; NO donors; Preeclampsia; Pregnancy

Indexed keywords

GLYCERYL TRINITRATE; N ACETYL S NITROSOPENICILLAMINE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ARTERY; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; VEIN; VEIN DILATATION;

EID: 1842292771     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291861     Document Type: Article

References (31)

1. Robson CC, Hunter S, Boys RJ. Dunlop W: Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989;256:H1060-H1065.
2. Nisell H, Hjemdahl P, Linde B: Cardiovascular responses to circulating catecholamines in normal pregnancy and in prcgnancy-induccd hypertension. Clin Physiol 1985;5:479-493.
3. Grocncndijk R. Trimbos JB, Wallcnburg HC: Hemodynamic measurement in prceclampsia: Preliminary observations. Am J Obstet Gynecol 1984;150:232-236.
4. Belfort MA. Saadc GR. Suresh M. Johnson D. Vedernikov V: Human umbilical vessels: Responses to agents frequently used in obstetric patients. Am J Obstet Gynecol 1995; 172: 1395-1403.
5. Fox SB. Khong TY: Lack of innervation of human umbilical cord. An immunohistological and histochemical study. Placenta 1990:11:59-62.
6. Boura AL, Walters WA: Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta 1991; 12:453-477.
7. Moncasa S. Higgs A: The 1-arginine nitric oxide pathway. N Engl J Med 1993:329:2002-2012.
8. Myatt L, Brewer A, Brockman DE: The action of nitric oxide in the perfused human fctal-pla-cental circulation. Am J Obstet Gynecol 1991; 164:687-692.
9. McLauhlin MK, Conrad KP: Nitric oxide biosynthesis during pregnancy: Implications for circulatory changes. Clin Exp Pharmacol Physiol 1995;22:164-171.
10. Pinto A, Sorrentino R, Sorrentino P. Guerri-tore T, Miranda L. Biondi A, Martinelli P: Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507-513.
11. Seligman SP. Buyon JP, Clancy RM. Young BK, Abramson SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994;171:944-948.
12. Feelish M: The biochemical pathways of nitric oxide formation from vasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous solutions. J Cardiovasc Pharmacol 1991:17: S25-S33.
13. Feelish M, Kelm M: Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1991; 180:286-293.
14. MacAllister RJ, Calver AL, Riezebos J, Collier J, Vallance P: Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: An insight into the targeting of nitric oxide delivery. J Pharmacol Exp Ther 1995:273:154-160.
15. González C, Cruz MA. Gallardo V. Albornoz J. Bravo I: Serotonin-induced vasoconstriction in human placental chorionic veins: Interaction with PGFjo. Gynecol Obstet Invest 1993;35: 86-90.
16. Morris NH, Eaton BM. Dekker G: Nitric oxide. the endothelium, pregnancy and prceclampsia. Br J Obstet Gynaecol 1996:103:4-15.
17. Dadak C, Olrich W. Sinzinger H: Morphological changes in the umbilical arteries of babies bom to pre-eclamptic mothers: An ultrastructural study. Placenta 1984;5:419-426.
18. Gonzalez C, Cruz MA, Gallardo V, Lagos M. Varela J. Albornoz J, Schulz C: Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest 1995;40:244-248.
19. Cotton DB, Longmire S. Jones MM. Dorman KF, Tessem J, Joyce TH: Cardiovascular alterations in severe pregnancy-induced hypertension: Effects of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol 1986;154:1053-1059.
20. Longmire S, Leduc L, Jones MM, Hawkins JL, Joyce TH, Cotton DB: The hemodynamic effects of intubation during nitroglycerin infusion in severe preeclampsia. Am J Obstet Gynecol 1991;164:551-556.
21. Grünewald C, Kublickas M, Carlstrom K, Lundi N, Nisell H: Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 1995:86:600-604.
22. Giles W, O’Callaghan S, Boura A, Walters W: Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet 1992;340:856.
23. Baker AB: Management of severe pregnancy-induced hypertension, or gestosis, with sodium nitroprusside. Anaesth Intensive Care 1990:18: 361-365.
24. Panza JN, Casino PR. Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-1474.
25. Barton JR, Sibai BM, Ahokas RA, Whybrew WD, Mercer BM: Magnesium sulphate therapy in pre-cclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol 1992;167:931-934.
26. Lopcz-Jaramillo P, Narvaez M, Calle A. Rivera J, Jàcome P. Ruano C, Nava E: Cyclic guanosine 3',5'monophosphate concentrations in pre-eclampsia: Effects of hydralazine. Br J Obstet Gynaecol 1996:103:33-38.
27. Armstrong JA, Marks GS, Armstrong PW: Absence of metabolite formation during nitroglycerin-induced relaxation of isolated blood vessels. Mol Pharmacol 1980,18:112-116.
28. Yang ZH, von Segesscr L, Bauer E, Stulz P, Turina M, Lüscher TF: Different activation of the endothelial L-argininc and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 1991;68:52-60.
29. Moneada S, Rees D, Schulz R. Palmer RJ: Development and mechanism of a specific su-persensitivite to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991:88:2166-2170.
30. Cruz MA. Gonzalez C, Gallardo V, Albornoz J. Muñoz ME, Lagos M: Endothelial modulation of vascular tone and 5-hydroxytryptamine-in-duccd responses in human chorionic arteries and veins. Gen Pharmacol 1995:26:1571-1577.
31. Bauer JA, Fung HL: Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther 1991:256: 249-254.